Post-Conference Perspectives: Understanding HER2-Low Breast Cancer
home / news-network / post-conference-perspectives-understanding-her2-low-breast-cancer
Experts Sandra M. Swain, MD, and Zahi Mitri, MD, MS, reflect on HER2-low breast cancer as a subset of disease and discuss novel therapeutic agents that may improve patient outcomes in this setting.